Danaher Corporation $DHR Shares Newly Purchased by Machina Capital S.A.S.

Machina Capital S.A.S. bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the 3rd quarter, according to its most recent filing with the SEC. The firm bought 6,855 shares of the conglomerate’s stock, valued at approximately $1,519,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Riverbridge Partners LLC lifted its position in shares of Danaher by 9.0% during the third quarter. Riverbridge Partners LLC now owns 243,517 shares of the conglomerate’s stock worth $53,951,000 after purchasing an additional 20,113 shares in the last quarter. Silver Grove Financial Group Inc. grew its holdings in Danaher by 27.5% during the 3rd quarter. Silver Grove Financial Group Inc. now owns 408 shares of the conglomerate’s stock valued at $90,000 after purchasing an additional 88 shares in the last quarter. AMG National Trust Bank grew its holdings in Danaher by 1.9% during the 3rd quarter. AMG National Trust Bank now owns 18,411 shares of the conglomerate’s stock valued at $4,079,000 after purchasing an additional 344 shares in the last quarter. Csenge Advisory Group increased its stake in Danaher by 105.3% during the 3rd quarter. Csenge Advisory Group now owns 4,749 shares of the conglomerate’s stock worth $1,052,000 after buying an additional 2,436 shares during the period. Finally, 71 West Capital Partners increased its stake in Danaher by 11.0% during the 3rd quarter. 71 West Capital Partners now owns 4,794 shares of the conglomerate’s stock worth $1,062,000 after buying an additional 476 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have weighed in on DHR shares. Royal Bank Of Canada upped their price objective on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Monday, October 26th. Guggenheim increased their price target on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. DZ Bank lowered Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Finally, Robert W. Baird lifted their price objective on Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $242.91.

Insider Buying and Selling

In other news, EVP Gregory Milosevich sold 2,100 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the sale, the executive vice president directly owned 22,367 shares in the company, valued at approximately $5,158,277.54. The trade was a 8.58% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 10.80% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of DHR stock opened at $232.08 on Friday. The firm has a market cap of $163.28 billion, a P/E ratio of 37.98, a P/E/G ratio of 2.95 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a fifty day moving average of $222.11 and a two-hundred day moving average of $201.53.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company’s revenue was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.89 EPS. As a group, research analysts anticipate that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were given a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio (DPR) is presently 26.19%.

Danaher Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.